SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020536
Filing Date
2018-08-08
Accepted
2018-08-08 16:37:29
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 SGMO-Q2_20180630 sgmo-10q_20180630.htm 10-Q 1753930
2 EX-10.9 sgmo-ex109_61.htm EX-10.9 113058
3 EX-31.1 sgmo-ex311_9.htm EX-31.1 15468
4 EX-31.2 sgmo-ex312_8.htm EX-31.2 15812
5 EX-32.1 sgmo-ex321_10.htm EX-32.1 7612
  Complete submission text file 0001564590-18-020536.txt   6549861

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgmo-20180630.xml EX-101.INS 1596823
7 XBRL TAXONOMY EXTENSION SCHEMA sgmo-20180630.xsd EX-101.SCH 40751
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgmo-20180630_cal.xml EX-101.CAL 35499
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgmo-20180630_def.xml EX-101.DEF 161915
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmo-20180630_lab.xml EX-101.LAB 273641
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmo-20180630_pre.xml EX-101.PRE 227289
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 181001923
SIC: 2836 Biological Products, (No Diagnostic Substances)